-
Biologics buy and bill – buyer beware
Buy and bill for biologics was a hot topic this past weekend at the 2018 Annual Scientific Meeting in Seattle. During a presentation titled “Biologic The…
-
Trump Administration proposes a new drug pricing plan
The Trump Administration recently issued what is called an “Advanced” Notice of Proposed Rulemaking (ANPRM) to consider changes to what and how Medicare Part B…
-
Medicare disaster plan in wake of Hurricane Florence
An advisory was issued from the Centers for Medicare and Medicaid Services.
-
Can’t stop, won’t stop
While the Advocacy Council had recently submitted extensive comments to the Centers for Medicare and Medicaid Services (CMS) regarding the 2019 Proposed Medica…
-
Clarification of CMS’ proposal for multiple procedure payment reduction
The Advocacy Council has heard from many allergists who are concerned about the impact of the Center for Medicare and Medicaid Services’ (CMS’) pro…
-
We’re fighting for your practice
Last week we reported that the College and Academy leadership had met with the Centers for Medicare and Medicaid Services (CMS). We also recently sent this let…
-
我们让CMS知道我们ll feel
It has been a very busy couple of weeks for the Advocacy Council. In cooperation with the AAAAI Committee on Advocacy, we continue to work on multiple fronts r…
-
Advocacy Council of the ACAAI to oppose proposed 2019 Medicare payment reductions for allergy/immunology
CMS发布了言之凿凿ed Medicare Physician Fee Schedule Rule for 2019, which includes substantial Medicare payment reductions for A/I.
-
Coding questions? We’ve got answers!
The Advocacy Council has long been the go-to source when you’ve needed an answer to coding and/or reimbursement questions. We understand coding correctly…
-
CMS’ proposed E&M changes: what’s next?
Last week the Advocacy Insider outlined the potential impact of the proposed collapse of the E&M codes, published in the July 27 Federal Register by t…
-
Your thoughts on drug pricing are needed
A cornerstone of President Trump’s campaign platform was a solution to the ever-increasing cost of prescription drugs. Recently, the administration relea…
-
You probably know about this, but…
Over the last several months, The Centers for Medicare and Medicaid (CMS) has informed Medicare recipients that new cards would be coming soon. The Medicare Ac…
-
Venom extract – what’s next?
The Advocacy Council and the College are aware of and understand the financial impact the venom extract issue is having on providing venom testing and immunoth…
-
What are the codes for SLIT? We’ve got it!
The Advocacy Council often gets questions from College members wondering what the correct codes for SLIT are. Luckily, we’ve got the answers!What are the…
-
Administration’s Drug Pricing Proposal
By now you have probably heard about the President’s new drug pricing proposal which was announced on May 11. The President had campaigned on the issue o…
-
Medicare E&M documentation – Is there relief in sight?
Documentation requirements for evaluation and management (E&M) services are a subject that provokes the ire of almost all physicians regardless of specialt…
-
Billing for venom testing and immunotherapy
As we noted in last week’s Insider, there continues to be concerns about pricing and adequate availability of venoms for testing and treatment. We also u…
-
Venom extract price seems stable for now
The ACAAI and American Academy of Allergy, Asthma & Immunology recognize that there are growing concerns among our members regarding venom immunotherapy re…
-
CMS announces three major changes
The Centers for Medicare and Medicaid Services (CMS) has recently announced it will begin to implement major changes to electronic health records’ (EHRs)…
-
What do you know about 95165?
Communications we have received recently from members suggest there may still be some confusion as to Medicare rules for allergy immunotherapy billing (CPT Cod…